Literature DB >> 27989534

Corrigendum to "The Epidemiology of Renal Cell Carcinoma" [Eur Urol 2011;60:615-21].

Börje Ljungberg1, Steven C Campbell2, Han Yong Choi3, Didier Jacqmin4, Jung Eun Lee5, Steffen Weikert6, Lambertus A Kiemeney7.   

Abstract

Entities:  

Year:  2011        PMID： 27989534     DOI： 10.1016/j.eururo.2011.09.001

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  11 in total

1.  Assessment of multiphasic contrast-enhanced MR textures in differentiating small renal mass subtypes.

Authors:  Uyen N Hoang; S Mojdeh Mirmomen; Osorio Meirelles; Jianhua Yao; Maria Merino; Adam Metwalli; W Marston Linehan; Ashkan A Malayeri
Journal:  Abdom Radiol (NY)       Date:  2018-12

2.  (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels.

Authors:  Yasemin Akbulut; Hannah J Gaunt; Katsuhiko Muraki; Melanie J Ludlow; Mohamed S Amer; Alexander Bruns; Naveen S Vasudev; Lea Radtke; Matthieu Willot; Sven Hahn; Tobias Seitz; Slava Ziegler; Mathias Christmann; David J Beech; Herbert Waldmann
Journal:  Angew Chem Int Ed Engl       Date:  2015-02-23       Impact factor: 15.336

Review 3.  Novel immunotherapy in metastatic renal cell carcinoma.

Authors:  Yang Hyun Cho; Myung Soo Kim; Ho Seok Chung; Eu Chang Hwang
Journal:  Investig Clin Urol       Date:  2017-06-20

4.  Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.

Authors:  Johannes Mischinger; Eleonore Fröhlich; Sebastian Mannweiler; Claudia Meindl; Markus Absenger-Novak; Georg C Hutterer; Maximilian Seles; Herbert Augustin; Thomas F Chromecki; Johanna Jesche-Chromecki; Karl Pummer; Richard Zigeuner
Journal:  Cent European J Urol       Date:  2019-03-14

5.  LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.

Authors:  Er-Lin Song; Li Xing; Liang Wang; Wen-Ting Song; Dan-Bin Li; Yi Wang; Yi-Wei Gu; Ming-Ming Liu; Wen-Jun Ni; Peng Zhang; Xin Ma; Xu Zhang; Jie Yao; Yang Chen; Rui-Hua An
Journal:  Aging (Albany NY)       Date:  2019-08-10       Impact factor: 5.682

6.  Inhibition of BRD4 prevents proliferation and epithelial-mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis.

Authors:  Yi-Fan Tan; Min Wang; Zhi-Yuan Chen; Lei Wang; Xiu-Heng Liu
Journal:  Cell Death Dis       Date:  2020-04-17       Impact factor: 8.469

7.  Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.

Authors:  Junjie Cen; Yanping Liang; Yong Huang; Yihui Pan; Guannan Shu; Zhousan Zheng; Xiaozhong Liao; Mi Zhou; Danlei Chen; Yong Fang; Wei Chen; Junhang Luo; Jiaxing Zhang
Journal:  Mol Cancer       Date:  2021-01-20       Impact factor: 27.401

8.  Targeting the testis-specific heat-shock protein 70-2 (HSP70-2) reduces cellular growth, migration, and invasion in renal cell carcinoma cells.

Authors:  Swarnendra Singh; Anil Suri
Journal:  Tumour Biol       Date:  2014-09-12

9.  TOFA induces cell cycle arrest and apoptosis in ACHN and 786-O cells through inhibiting PI3K/Akt/mTOR pathway.

Authors:  Dejiao He; Xuan Sun; Hongxia Yang; Xiaoli Li; Dingping Yang
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

10.  Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning.

Authors:  Ignacio Durán; Daniel Castellano; Javier Puente; Lidia Martín-Couce; Esther Bello; Urbano Anido; José Manuel Mas; Luis Costa
Journal:  Oncotarget       Date:  2022-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.